The company is a continuation of the journey she started earlier aiming at developing innovative solutions in drug discovery. The company aims at integrating experts chemistry knowledge with advanced ML to enable rapid discovery of new chemical entities of desired properties. Shaker and Glamorous AI have established relationships within academia, such as Cardiff University to discover possible Covid-19 drugs using Glamorous AI's platform, Rosalind.